Showing results (31-40 of 5,171) with videos related to
Sort By:
Pageof 518
International Journal of Clinical Pharmacology and Therapeutics|June 5, 2003
Scaling or wider bioequivalence limits for highly variable drugs and for the special case of C(max)L Tothfalusi, L Endrenyi, K K MidhaJournal of Toxicology and Environmental Health|December 1, 1993
Percutaneous uptake, distribution, and excretion of pyrene in ratsJ R Withey, F C Law, L EndrenyiJournal of Neurosurgery|December 1, 1980
The value of decompression for acute experimental spinal cord compression injuryE J Dolan, C H Tator, L EndrenyiJournal of Clinical Pharmacology|April 1, 1985
Plasma concentration-response relationships of two formulations of propranololL D DeLeve, L Endrenyi, F H LeenenJournal of Toxicology and Environmental Health|April 1, 1991
Pharmacokinetics and bioavailability of pyrene in the ratJ R Withey, F C Law, L EndrenyiBritish Journal of Anaesthesia|June 1, 1975
Calcium uptake into muscle of pigs susceptible to malignant hyperthermia: in vitro and in vivo studies with and without halothaneB A Britt, L Endrenyi, D L CadmanPharmaceutical Research|July 11, 2000
Sensitivity of empirical metrics of rate of absorption in bioequivalence studiesA Ring, L Tothfalusi, L Endrenyi, et al.The Journal of Biological Chemistry|November 15, 1987
Forskolin-resistant Y1 mutants harbor defects associated with the guanyl nucleotide-binding regulatory protein, GsB P Schimmer, J Tsao, R Borenstein, et al.Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1978
Enzyme induction following a single dose of amobarbital in dogsP A Reilly, T Inaba, D Kadar, et al.Pharmaceutical Research|August 26, 1998
Metrics comparing simulated early concentration profiles for the determination of bioequivalenceL Endrenyi, F Csizmadia, L Tothfalusi, et al.Pageof 518